253 related articles for article (PubMed ID: 38207106)
1. Proteomic, Metabolomic, and Fatty Acid Profiling of Small Extracellular Vesicles from Glioblastoma Stem-Like Cells and Their Role in Tumor Heterogeneity.
Lokumcu T; Iskar M; Schneider M; Helm D; Klinke G; Schlicker L; Bethke F; Müller G; Richter K; Poschet G; Phillips E; Goidts V
ACS Nano; 2024 Jan; 18(3):2500-2519. PubMed ID: 38207106
[TBL] [Abstract][Full Text] [Related]
2. Extracellular vesicles in the biology of brain tumour stem cells--Implications for inter-cellular communication, therapy and biomarker development.
Nakano I; Garnier D; Minata M; Rak J
Semin Cell Dev Biol; 2015 Apr; 40():17-26. PubMed ID: 25721810
[TBL] [Abstract][Full Text] [Related]
3. Extracellular Vesicles from High-Grade Glioma Exchange Diverse Pro-oncogenic Signals That Maintain Intratumoral Heterogeneity.
Ricklefs F; Mineo M; Rooj AK; Nakano I; Charest A; Weissleder R; Breakefield XO; Chiocca EA; Godlewski J; Bronisz A
Cancer Res; 2016 May; 76(10):2876-81. PubMed ID: 27013191
[TBL] [Abstract][Full Text] [Related]
4. Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.
Garner JM; Ellison DW; Finkelstein D; Ganguly D; Du Z; Sims M; Yang CH; Interiano RB; Davidoff AM; Pfeffer LM
PLoS One; 2015; 10(5):e0125838. PubMed ID: 25955030
[TBL] [Abstract][Full Text] [Related]
5. Transfer of MicroRNA via Macrophage-Derived Extracellular Vesicles Promotes Proneural-to-Mesenchymal Transition in Glioma Stem Cells.
Zhang Z; Xu J; Chen Z; Wang H; Xue H; Yang C; Guo Q; Qi Y; Guo X; Qian M; Wang S; Qiu W; Gao X; Zhao R; Guo X; Li G
Cancer Immunol Res; 2020 Jul; 8(7):966-981. PubMed ID: 32350000
[TBL] [Abstract][Full Text] [Related]
6. Glioma-derived small extracellular vesicles induce pericyte-phenotype transition of glioma stem cells under hypoxic conditions.
Cheng Y; Li S; Hou Y; Wan W; Wang K; Fu S; Yuan Y; Yang K; Ye X
Cell Signal; 2023 Sep; 109():110754. PubMed ID: 37315748
[TBL] [Abstract][Full Text] [Related]
7. NSG-70, a new glioblastoma cell line with mixed proneural-mesenchymal features, associates NOTCH1-WNT5A signaling with stem cell maintenance and angiogenesis.
Singh DK; Shivalingappa PKM; Sharma A; Mondal A; Muzumdar D; Shiras A; Bapat SA
J Neurooncol; 2022 May; 157(3):575-591. PubMed ID: 35430703
[TBL] [Abstract][Full Text] [Related]
8. Glioblastoma Stem Cell-Derived Exosomes Enhance Stemness and Tumorigenicity of Glioma Cells by Transferring Notch1 Protein.
Sun Z; Wang L; Zhou Y; Dong L; Ma W; Lv L; Zhang J; Wang X
Cell Mol Neurobiol; 2020 Jul; 40(5):767-784. PubMed ID: 31853695
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA Signatures and Molecular Subtypes of Glioblastoma: The Role of Extracellular Transfer.
Godlewski J; Ferrer-Luna R; Rooj AK; Mineo M; Ricklefs F; Takeda YS; Nowicki MO; Salińska E; Nakano I; Lee H; Weissleder R; Beroukhim R; Chiocca EA; Bronisz A
Stem Cell Reports; 2017 Jun; 8(6):1497-1505. PubMed ID: 28528698
[TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p.
Yin J; Ge X; Shi Z; Yu C; Lu C; Wei Y; Zeng A; Wang X; Yan W; Zhang J; You Y
Theranostics; 2021; 11(4):1763-1779. PubMed ID: 33408780
[No Abstract] [Full Text] [Related]
11. Temozolomide affects Extracellular Vesicles Released by Glioblastoma Cells.
André-Grégoire G; Bidère N; Gavard J
Biochimie; 2018 Dec; 155():11-15. PubMed ID: 29454008
[TBL] [Abstract][Full Text] [Related]
12. CD133+ glioblastoma stem-like cells induce vascular mimicry in vivo.
Chiao MT; Yang YC; Cheng WY; Shen CC; Ko JL
Curr Neurovasc Res; 2011 Aug; 8(3):210-9. PubMed ID: 21675958
[TBL] [Abstract][Full Text] [Related]
13. Angiocrine extracellular vesicles impose mesenchymal reprogramming upon proneural glioma stem cells.
Adnani L; Kassouf J; Meehan B; Spinelli C; Tawil N; Nakano I; Rak J
Nat Commun; 2022 Sep; 13(1):5494. PubMed ID: 36123372
[TBL] [Abstract][Full Text] [Related]
14. Extracellular sphingosine-1-phosphate: a novel actor in human glioblastoma stem cell survival.
Riccitelli E; Giussani P; Di Vito C; Condomitti G; Tringali C; Caroli M; Galli R; Viani P; Riboni L
PLoS One; 2013; 8(6):e68229. PubMed ID: 23826381
[TBL] [Abstract][Full Text] [Related]
15. Decreased Equilibrative Nucleoside Transporter 1 (ENT1) Activity Contributes to the High Extracellular Adenosine Levels in Mesenchymal Glioblastoma Stem-Like Cells.
Alarcón S; Toro MLÁ; Villarreal C; Melo R; Fernández R; Ayuso Sacido A; Uribe D; San Martín R; Quezada C
Cells; 2020 Aug; 9(8):. PubMed ID: 32824670
[TBL] [Abstract][Full Text] [Related]
16. Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization.
Garnier D; Meehan B; Kislinger T; Daniel P; Sinha A; Abdulkarim B; Nakano I; Rak J
Neuro Oncol; 2018 Jan; 20(2):236-248. PubMed ID: 29016925
[TBL] [Abstract][Full Text] [Related]
17. Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.
Wakimoto H; Mohapatra G; Kanai R; Curry WT; Yip S; Nitta M; Patel AP; Barnard ZR; Stemmer-Rachamimov AO; Louis DN; Martuza RL; Rabkin SD
Neuro Oncol; 2012 Feb; 14(2):132-44. PubMed ID: 22067563
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicles produced by irradiated endothelial or Glioblastoma stem cells promote tumor growth and vascularization modulating tumor microenvironment.
Castellani G; Buccarelli M; D'Alessandris QG; Ilari R; Cappannini A; Pedini F; Boe A; Lulli V; Parolini I; Giannetti S; Biffoni M; Zappavigna V; Marziali G; Pallini R; Ricci-Vitiani L
Cancer Cell Int; 2024 Feb; 24(1):72. PubMed ID: 38347567
[TBL] [Abstract][Full Text] [Related]
19. Molecular subtypes and differentiation programmes of glioma stem cells as determinants of extracellular vesicle profiles and endothelial cell-stimulating activities.
Spinelli C; Montermini L; Meehan B; Brisson AR; Tan S; Choi D; Nakano I; Rak J
J Extracell Vesicles; 2018; 7(1):1490144. PubMed ID: 30034643
[TBL] [Abstract][Full Text] [Related]
20. Stem cell signature in glioblastoma: therapeutic development for a moving target.
Nakano I
J Neurosurg; 2015 Feb; 122(2):324-30. PubMed ID: 25397368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
